Thermo Fisher Scientific Obtains CE-IVD Mark for PCR-Based GI Bacteria Panel
The assay, registered under IVDD this May, can detect a range of common GI bacteria in stool samples with more than 98 percent sensitivity and specificity.
Ophiomics Liver Cancer Assay Gets CE-IVD Mark
Biocartis is launching the HepatoPredict gene expression assay to help predict the benefits of liver transplant in hepatocellular carcinoma patients.
The Cobas Pure Integrated Solutions combines clinical chemistry, immunochemistry, and ion-selective electrode tests onto one platform.
Roche Obtains CE Mark for Three Tests on New Cobas PCR Instrument
The newly launched tests join the existing menu of infectious disease assays, including ones for HIV, SARS-CoV-2, and chlamydia and gonorrhea.
BillionToOne, UCSD Partner to Assess New Liquid Biopsy Assays in Lung Cancer
Investigators are evaluating the firm's tumor profiling and treatment response monitoring assays and expect initial results in a few months.